Recently, it has been described that dopamine (DA), via dopaminergic type 2 receptors (D 2 R), activates the mitogen-activated protein kinase (MAPK/ERK) proteins in alveolar epithelial cells (AEC), which results in the upregulation of the Na,K-ATPase. In the present report, we used AEC to investigate the signaling pathway that links DA with ERK activation. Incubation of AEC with DA resulted in a rapid and transient stimulation of ERK activity, which was mediated by Ras proteins and the serine/threonine kinase Raf-1. Pre-treatment of AEC with SH3b-P, a peptide that blocks the interaction between Grb2 and SOS, did not prevent DA activation of ERK. DAG-dependent PKC isoenzymes were involved in the DA-mediated activation of ERK proteins as pretreatment with either bisindolylmaleimide or Ro-31-8220 prevented the phosphorylation of Elk-1 and quinpirole, a dopaminergic-type 2 receptor activator, stimulates the translocation of PKCε. Taken together the data suggest that DA activated MAPK/ERK via Ras, Raf-1 kinase and DAG-dependent PKC isoenzymes but, importantly and contrary to the classical model, this pathway did not involve the Grb2-SOS complex formation.
INTRODUCTION
Dopamine (DA) regulates ion channels to modulate the excitability of neurons and also activates second-messenger systems that in turn activate protein kinase cascades and transcription factors (46) . DA, via dopaminergic type 1 receptor (D 1 R), has been reported to increase lung liquid clearance in normal and injured lungs (2, 3, 47) . Recently, we have also observed that stimulation of dopaminergic type 2 receptors (D 2 R) in alveolar epithelial cells (AEC) resulted in activation of Na,K-ATPase via MAPK/ERK proteins by yet undescribed signaling pathways (19) .
The mitogen-activated protein kinase/extracellular-regulated kinase (MAPK/ERK) cascade is a major signaling system by which cells transduce extracellular signals into intracellular responses. Activation of ERK proteins classically involves ligand binding to a receptor tyrosine kinase (22) , although ERK proteins can also be activated by G-protein couple receptors (GPCR), such as the dopaminergic receptors (21, 62) . Activated receptors may interact with adaptor proteins, such as Grb2, which in turn, by SH3 domain-mediated interaction, bind and recruit the guanine nucleotide exchange factor SOS to the plasma membrane in proximity to Ras to exchange the GDP for GTP on Ras proteins (12, 28) . Once in the activated GTP-bound state, Ras associates with the serine/threonine kinase Raf-1, which is then activated by LCMP-00178-2001-R 5 buffer (MLB) containing 25 mM HEPES, pH 7.5; 150 mM NaCl, 1% igepal CA-630, 10 mM MgCl 2 , 1 mM EDTA, 2% glycerol, 1 mM Na 3 VO 4 , 25 mM NaF, 1mM PMSF, 10µg/ml aprotinin, 10µg/ml leupeptin. Fresh cell lysates were diluted to roughly 1µg/µl total cell protein with MLB and the lysates were precleared with glutathione agarose. After that, 500µg-1mg of cell lysate was incubated with 15µl Raf-1 RBD agarose conjugate per assay and the mixture was gently rocked at 4 o C for 30 min. Agarose beads were collected by pulsing and the supernatant was drained off. The beads were washed 3 times with MLB, resuspended in appropriate amount of Laemmli sample buffer and boiled for 5 min. Supernatants were collected and loaded on a 12% SDS-PAGE. The gel was transferred to nitrocellulose membrane and probed with 1µg/ml of anti-Ras, clone RAS10 (Upstate Biotechnology, Lake Placid, NY) overnight at 4 o C. A dilution of horseradish peroxidase conjugated antimouse antibody was used as the secondary antibody and the ECL reagents were used for the final protein detection.
Measurement of Raf-1 kinase activity. ATII cells were serum-starved for 20-24 h prior to stimulation with DA (10 µM) for 10 min or with 200 ng/ml EGF for 20 min. Raf-1 kinase activity was determined using the method described elsewhere (50) , based on the phosphorylation of syntide-2 (Santa Cruz Biotechnologies, Santa Cruz, CA), a Raf-1 substrate (25) .
Subcellular fractionation. Serum-starved cells were treated with different agonists and antagonists at the indicated times. Cells were washed twice with ice-cold PBS and scrapped into homogenization buffer containing: 20 mM Tris-HCl, pH, 7.4, 2 mM EGTA, 2 mM EDTA, 1 mM PMSF, 10 mM β-mercaptoethanol, 10 µg/ml aprotinin, and 10 µg/ml leupeptin. After 10 min incubation cells were homogenized with 30 strokes of a Dounce homogenizer using a tightfitting pestle. Nuclei were pelleted by centrifugation at 500 g for 5 min, and the low speed LCMP-00178-2001-R 6 supernatant was centrifuged 100,000g for 1h min. The high speed supernatant constituted the cytosolic fraction. The pellet was washed three times and extracted in ice-cold homogenization buffer containing 1% Triton X-100 for 1h. The triton-soluble component (membrane fraction) was separated from the triton-insoluble material (cytoskeletal fraction) by centrifugation at 100,000 g for 15 min. The cytoskeletal fraction was washed three times with homogenization buffer, resuspended in the same buffer and dispersed by sonication.
PKC translocation. Serum-starved cells were treated with the corresponding agonist at the indicated times and analysis by Western blotting, after subcellular fractionation, was performed to study the distribution of the different PKC isoenzymes in the cytosolic and membrane fractions.
Statistical analysis. Data are represented as mean ± SEM. When multiple comparisons were made a one-way analysis of variance was used, followed by a multiple comparison test (Tukey) when the F statistic indicated significance. Results were considered significant when p<0.05. Figure 2C showed that treatment of serum-starved ATII cells with 10µM DA for 5 min increased by 2.5
RESULTS

DA activates MAPK/ERK in ATII cells.
fold, the affinity precipitation of Ras-GTP by the agarose-conjugated RBD. We used EGF as a positive control of Ras activation and FTI inhibitors as negative regulators of Ras activation.
These experiments support the conclusion that Ras proteins participate in the DA-mediated ERK activation in AEC. with 1µM bisindolylmaleimide, a PKC inhibitor, 15 minutes prior to DA stimulation. We observed that this inhibitor completely blocked ERK activation induced by DA as well as by the PKC activator PMA, used as positive control of PKC-mediated ERK activation (56) . These results suggest that the DA-mediated ERK activation is dependent on PKC activity ( Figure 5 ).
To determine which specific PKC isoforms are involved in this pathway, we treated starved ATII cells with Ro-31-8220, that specifically inhibits DAG-dependent PKC isoforms (c-PKC, n-PKC). This inhibitor blocked the DA-dependent ERK activation similarly to the observed with bisindolylmaleimide, suggesting the involvement of classical and/or novel PKC isoforms ( Figure   6 ). Recently, we have shown that DA activates ERK via dopaminergic type 2 (D2) receptors (19) . To determine whether atypical PKC isoforms participate in the DA-ERK pathway, ATII cells were serum-starved and depleted of classical and novel PKC isoforms by incubation with PMA for 24 h. After this treatment, cells were treated with quinpirole, a D2 agonist, or PMA. As shown in Figure 7 , quinpirole did not activate ERK proteins in depleted cells, which indicates that atypical PKC isoenzymes are not involved in the DA-mediated ERK activation in ATII cells.
PKC isoenzymes translocate from one subcellular compartment to another when they are activated. Thus, to determine which specific PKC isoenzymes may have been involved in the DA-mediated ERK activation, we studied the subcellular distribution of several PKC isoforms in serum-starved ATII cells treated with quinpirole, after cellular fractionation and Western blotting using specific antibodies. The treatment was performed at short times, as PKCs translocation is transient and usually very fast. It has been described that ATII cells express the PKC isoforms α, β, δ, ε, η and ζ (29). Thus, we chose to study the activation of the classical PKCα and the novel isoform, PKCε. 
DISCUSSION
The major findings of the present study are that DA regulates ERK activity in alveolar epithelial cells via Ras, Raf-1 and novel PKC proteins but not the classical Grb2-SOS complex.
This study expands on our report that demonstrated the role of DA-ERK pathway on the regulation of the Na,K-ATPase in the alveolar epithelium (19) . DA regulates Na,K-ATPase short-term in AEC via D1 receptors, while D2 receptors appear to regulate the Na-pump longterm. Contrary to D2 receptors, which activate ERK in AEC, D1 receptors do not increase (as they appear to inhibit) ERK activity in AEC. Thus, it is possible that there may be even an antagonic effect of both pathways on ERK activation.
DA and other catecholamines have been shown to regulate ERK activity in different cells (13, 21, 40, 60, 62) . system. First, DA, via dopaminergic type 1 receptors, activates the serine/threonine phosphatase PP2A in AEC (27) . Second, the dual specificity phosphatases (DSP), a subclass of the protein tyrosine phosphatase family that dephosphorylate the phosphothreonine and phosphotyrosine residues within MAP kinases, are an important regulatory mechanism of the ERK function (10).
Further work is warranted to determine which specific phosphatases are participating in the DA-ERK pathway in alveolar epithelial cells. The inhibitory effect of the rasN17 on the stimulation of ERK by EGF, a known activator of the Grb2-SOS-Ras-ERK cascade (33), is of a lesser magnitude than on the stimulatory effect of DA (see Figure 2) . A possible explanation is that the activation of ERK by DA is weaker as compared to the activation by EGF and can be abolished by the dominant negative ras mutant, which only partially inactivated the stronger signal induced by EGF. Also, it has been shown that in some cell types, EGF can bypass Ras and Raf-1 and directly activate MEK (7, 18) . (50) .
The data depicted in Figure 4 suggest that Raf-1 kinase participates in the DA-ERK pathway. First, DA-dependent ERK activity was inhibited by forskolin. Second, inhibition of PKA further increased the DA-mediated ERK activation, which is in agreement with the inhibitory effect of the cAMP-PKA pathway on ERK activation. Third, DA stimulated Raf-1 kinase activity, measured as phosphorylation of syntide-2. Additionally, results in Figure 4B further confirmed that the activation of Raf-1 kinase and subsequently ERK by DA is independent on the Grb2-SOS complex. In summary, these data suggest that in alveolar epithelial cells, DA regulates ERK proteins via D 2 R, Ras, Raf-1 and novel PKC isoenzymes but not the classical Grb2-SOS complex (see Figure 9 ). Future studies are warranted to determine which Ras-GEF is the responsible for DA-mediated Ras activation as well as the components that signal from DA to PKC in the activation of ERK1/2 proteins in the alveolar epithelium. 
